TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Net Income

Annual figures by fiscal year, from SEC filings.

2000: -$700.0K2001: -$1.81M2002: -$2.11M2003: -$502.6K2004: -$8.76M2005: -$1.08M2006: -$1.77M2007: -$2.00M2008: -$5.45M2009: -$4.70M2010: -$4.12M2011: -$9.48M2012: -$12.21M2013: -$12.89M2014: -$2.97M2015: -$13.89M2016: -$47.22M2017: -$10.26M2018: -$14.35M2019: -$24.59M2020: -$20.77M2021: -$17.93M2022: -$47.76M2023: -$59.25M2024: -$29.36M2025: -$51.42M2026: -$69.69M-$69.69M
2000Net Income (USD)2026
Fiscal YearNet IncomeChange YoY
2026-$69.69M-35.5%
2025-$51.42M-75.1%
2024-$29.36M+50.4%
2023-$59.25M-24.0%
2022-$47.76M-166.3%
2021-$17.93M+13.7%
2020-$20.77M+15.5%
2019-$24.59M-71.4%
2018-$14.35M-39.9%
2017-$10.26M+78.3%
2016-$47.22M-240.1%
2015-$13.89M-367.9%
2014-$2.97M+77.0%
2013-$12.89M-5.5%
2012-$12.21M-28.8%
2011-$9.48M-129.9%
2010-$4.12M+12.2%
2009-$4.70M+13.8%
2008-$5.45M-172.4%
2007-$2.00M-12.8%
2006-$1.77M-63.7%
2005-$1.08M+87.6%
2004-$8.76M-1642.0%
2003-$502.6K+76.2%
2002-$2.11M-16.8%
2001-$1.81M-158.4%
2000-$700.0K—